Back to results
US 2019/0161430 A1Published application
Novel derivatives of curcuminoids and use thereof as an anticancer agent
AssigneeChina Medical University
InventorsSHENG-CHU KUO, KUO-HSIUNG LEE, CHANG-HAI TSAI, MIN-TSANG HSIEH, LING-CHU CHANG, HSIN-YI HUNG, HUI-YI LIN, JAI-SING YANG
Life of this patent
Estimating the term…
Abstract
A series of novel bis(hydroxymethyl) alkanoate derivatives of curcuminoids were designed, and synthesized, which show anticancer activity, and in particular to breast cancer, colon cancer, and prostate cancer.
Claims22
Compound having the following formula:
- wherein Ra, Rb, Ra′ and Rb′ independently are H, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 fluoroalkoxy, amino, amino(C1-C6 alkyl), nitro, heteroaryl, OH, —OC(═O)Rd, —OC(═O)ORd, or —OC(═O)N(Rd)2, wherein Rd is H, C1-C6 alkyl, or C1-C9 alkylol;
- Rc is H, C1-C6 alkyl, C3-C6 unsaturated alkyl with a double or triple bond, C1-C9 alkylol, C7-C12 arylalkyl, or —CH2-OC(═O)Rd;
- and Re and Re′ independently are H, C1-C6 alkyl, C1-C6 alkoxy;
- wherein at least one of Ra, Rb, Ra′, and Rb′ is —OC(═O)Rd, and Rd is a C3-C9 branched alkylol;
- wherein said compound is interconvertible between keto and enol forms, when Rc is H, or a pharmaceutically acceptable salt thereof.
2 more elements
(canceled)
(canceled)
Dependencies are inferred from the claim text.